This paper is in the following e-collection/theme issue:

#xEndocrinology (4) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Diabetes (187) Diabetes Self-Management (484) Obesity (75) Innovative Methods in Public Health and Surveillance (332) Decision Support for Health Professionals (1185)

Published on in Vol 5 (2024)

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2023.11.19.23298750v1, first published .
Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Authors of this article:

Tigran Makunts1 Author Orcid Image ;   Haroutyun Joulfayan2 Author Orcid Image ;   Ruben Abagyan1 Author Orcid Image
Article Authors Cited by (4) Tweetations (8) Metrics

Altmetric

Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.

Dimensions

Dimensions discovers Citations. Click the ‘details’ link for a full report.

Metrics Since Publication

Download .csv
Daily | Monthly | Annually